Merck Serono

Ten of Quintiles' customers did more than $100m in business last year

Mid-sized biopharma key to strategic partnerships, Quintiles CEO says

By Zachary Brennan

Strategic partnerships - always a hot-topic for CROs – are becoming almost exclusively a big issue for mid-sized biopharma, though small biopharma and large pharma companies are interested as well, Quintiles CEO Tom Pike said Monday at the Morgan Stanley...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers